initiated: TD Cowen Recommends Celldex Therapeutics Inc. (NASDAQ:CLDX) Stock to “an Outperform”
TD Cowen raised the price target for the Celldex Therapeutics Inc. (NASDAQ:CLDX) stock to “an Outperform”. The rating was released on December 20, 2023, according to finviz. The research report from Wells Fargo has initiated the stock to Underweight, with a price target set at $21. The stock was initiated by Jefferies, who disclosed in […]
